Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
1.
Electron. j. biotechnol ; 41: 56-59, sept. 2019. tab, graf
Article in English | LILACS | ID: biblio-1087166

ABSTRACT

Background: Chinese hamster ovary (CHO) cells are the most dependable mammalian cells for the production of recombinant proteins. Replication-incompetent retroviral vector (retrovector) is an efficient tool to generate stable cell lines. Multiple copies of integrated genes by retrovector transduction results in improved recombinant protein yield. HEK-293 and their genetic derivatives are principal cells for retrovector production. Retrovectors packaged in HEK-293 cells pose a risk of infectious agent transmission, such as viruses and mycoplasmas, from serum and packaging cells. Results: In this report, retrovectors were packaged in CHO cells cultured in chemically defined (CD) media. The retrovectors were then used to transduce CHO cells. This method can block potential transmission of infectious agents from serum and packaging cells. With this method, we generated glucagon-like protein-1 Fc fusion protein (GLP-1-Fc) stable expression CHO cell lines. Productivity of GLP-1-Fc can reach 3.15 g/L. The GLP-1-Fc protein produced by this method has comparable bioactivity to that of dulaglutide (Trulicity). These stable cell lines retain 95­100% of productivity after 40 days of continuous culture (~48­56 generations). Conclusions: Suspension CHO cells are clean, safe, and reliable cells for retrovector packaging. Retrovectors packaged from this system could be used to generate CHO stable cell lines for recombinant protein expression.


Subject(s)
Retroviridae , Recombinant Proteins/metabolism , CHO Cells/metabolism , Immunoglobulin Fc Fragments , Cell Line , Chromatography, Gel/methods , Disease Vectors , Glucagon-Like Peptide 1 , Tandem Mass Spectrometry , Batch Cell Culture Techniques
2.
Electron. j. biotechnol ; 27: 55-62, May. 2017. tab, graf
Article in English | LILACS | ID: biblio-1010296

ABSTRACT

Background: To reduce costs associated with productivity of recombinant proteins in the biopharmaceutical industry, research has been focused on regulatory principals of growth and survival during the production phases of the cell culture. The main strategies involve the regulation of cell proliferation by the modulation of cell cycle control points (G1/S or G2/M) with mild hypothermia and the addition of sodium butyrate (NaBu). In this study, batch culture strategies were evaluated using CHO TF 70R cells producing the recombinant human tissue plasminogen activator (rh-tPA), to observe their individual and combined effect on the cellular physiological state and relevant kinetic parameters. Results: NaBu addition has a negative effect on the mitochondrial membrane potential (ΔΨm), the values of which are remarkably diminished in cultures exposed to this cytotoxic compound. This effect was not reflected in a loss of cell viability. NaBu and mild hypothermic conditions increased the doubling time in the cell cultures, suggesting that these strategies triggered a general slowing of each cell cycle phase in a different way. Finally, the individual and combined effect of NaBu and mild hypothermia produced an increase in the specific rh-tPA productivity in comparison to the control at 37°C without NaBu. Nevertheless, both strategies did not have a synergistic effect on the specific productivity. Conclusions: The combination of NaBu addition and mild hypothermic condition causes an impact on physiological and metabolic state of CHO TF 70R cells, decreasing cell growth rate and improving glucose consumption efficiency. These results therefore provide a promising strategy to increase specific productivity of rh-tPA.


Subject(s)
Recombinant Proteins/metabolism , CHO Cells/metabolism , Tissue Plasminogen Activator/metabolism , Butyric Acid/metabolism , Hypothermia , Cell Cycle , Cell Survival , CHO Cells/physiology , Tissue Plasminogen Activator/biosynthesis , Cell Proliferation , Membrane Potential, Mitochondrial
3.
Electron. j. biotechnol ; 16(3): 10-10, May 2013. ilus, tab
Article in English | LILACS | ID: lil-684008

ABSTRACT

Background: The production of recombinant proteins for therapeutic use represents a great impact on the biotechnology industry. In this context, established mammalian cell lines, especially CHO cells, have become a standard system for the production of such proteins. Their ability to properly configure and excrete proteins in functional form is an enormous advantage which should be contrasted with their inherent technological limitations. These cell systems exhibit a metabolic behaviour associated with elevated cell proliferation which involves a high consumption of glucose and glutamine, resulting in the rapid depletion of these nutrients in the medium and the accumulation of ammonium and lactate. Both phenomena contribute to the limitation of cell growth, the triggering of apoptotic processes and the loss of quality of the recombinant protein. Results: In this review, the use of alternative substrates and genetic modifications (host cell engineering) are analyzed as tools to overcome those limitations. In general, the results obtained are promising. However, metabolic and physiological phenomena involved in CHO cells are still barely understood. Thus, most of publications are focused on specific modifications rather than giving a systemic perspective. Conclusions: A deeper insight in the integrated understanding of metabolism and cell mechanisms is required in order to define complementary strategies at these two levels, so providing effective means to control nutrients consumption, reduce by-products and increase process productivity.


Subject(s)
Recombinant Proteins/biosynthesis , Cells/metabolism , Mammals/metabolism , CHO Cells/metabolism , Energy Metabolism , Cell Engineering , Glutamine/metabolism , Glycolysis
4.
P. R. health sci. j ; 18(3): 257-65, sept. 1999. ilus, tab, graf
Article in English | LILACS | ID: lil-255635

ABSTRACT

Rat gene 33 (g33) mRNA has a widespread tissue distribution. Insulin and various agents such as glucocorticoids, phorbol esters and plant lectins regulate G33 expression in rat hepatoma cells. The regulation of g33 by insulin and a phorbol ester was examined in two Chinese Hamster ovary (CHO) cell lines, CHO-T cells (which overexpress human insulin receptors (hIR)) and wild type CHOwt cells. These cell lines were used to determine how expression of the hIR influences the capacity of g33 to respond to insulin and phorbol myristate acetate (PMA). Treatment of CHOwt and CHO-T cells with insulin increased mRNAg33 levels three to four-fold, with a maximum effect reached after three hours of treatment. PMA treatment of CHOwt and CHO-T cells caused a similar elevation of mRNAg33 levels after three hours. Insulin had no effect on mRNAg33 stability in both CHO cell lines. Additionally, the effects of insulin and PMA on mRNAg33 levels were additive only in CHO-T cells. Insulin or PMA-pretreated CHO-T cells were able to respond to both agents, but elevation ofmRNAg33 levels was maximal. In contrast, when insulin and/or PMA-pretreated CHOwt cells were exposed to insulin or PMA, g33 was able to respond maximally. These results suggest that insulin and phorbol esters act through different signaling mechanisms in CHOwt cells. Additionally, insulin's ability to stimulate g33 expression in CHOwt cells suggests that this insulin effect may be independent of the insulin eceptor. There are differences in the regulation pattern of g33 by insulin and PMA in rat hepatoma and among the two CHO cell lines used in this study


Subject(s)
Humans , Animals , Cricetinae , Rats , CHO Cells , Gene Expression Regulation , Insulin/pharmacology , RNA, Messenger/analysis , Tetradecanoylphorbol Acetate/pharmacology , Antibiotics, Antineoplastic/pharmacology , Blotting, Northern , CHO Cells/metabolism , Dactinomycin/pharmacology , Nucleic Acid Synthesis Inhibitors/pharmacology , Insulin/physiology , Receptor, Insulin/physiology , Gene Expression Regulation , RNA, Messenger/adverse effects , RNA, Messenger/isolation & purification
5.
Article in English | IMSEAR | ID: sea-24173

ABSTRACT

The prevalence of Salmonella enterotoxin (stn) gene among different Salmonella serovars by using polymerase chain reaction (PCR) and its status of expression on the Chinese hamster ovary (CHO) cells were investigated. All the 26 strains of Salmonella enterica such as serovars Typhimurium, Enteritidis, Dublin, Typhi, Newport, Weltevreden, Gallinarum, etc. investigated in this study were found to carry stn gene as examined by the PCR and gene probe. However, only a limited number of stn positive strains (34.6%) were found to express phenotypically the Salmonella enterotoxin (Stn) as tested by the CHO cell assay. The strains of S. bongori were found to be negative for Stn production both genotypically and phenotypically.


Subject(s)
Animals , CHO Cells/metabolism , Cricetinae , Enterotoxins/genetics , Phenotype , Salmonella/classification , Serotyping , Species Specificity
6.
Article in English | IMSEAR | ID: sea-25488

ABSTRACT

Nineteen strains of Salmonella enterica belonging to seven serovars and two strains of S. bongori were investigated for enterotoxin production by the Chinese hamster ovary (CHO) cell assay and Dot-ELISA. All the 19 strains were found to carry stn gene when tested by polymerase chain reaction (PCR) using specific primers for stn sequence. Thirteen strains (68.42%) were found to produce Salmonella enterotoxin (Stn) when tested by the CHO cell assay. Dot-ELISA could detect Stn in 16 strains (84.21%). Dot-ELISA may be preferred over other assays due to its low cost and simplicity in performance.


Subject(s)
Animals , Bacterial Proteins/genetics , CHO Cells/metabolism , Cricetinae , Enzyme-Linked Immunosorbent Assay/methods , Polymerase Chain Reaction , Salmonella/classification , Serotyping
SELECTION OF CITATIONS
SEARCH DETAIL